What Moringa Ventures does

Moringa Ventures is a Singapore-based deep-tech venture builder established in 2025 and operationally backed by Tembusu Partners, a CMS-licensed multi-stage private equity firm founded in 2006. The firm writes first cheques (from S$250,000) into early-stage deep-tech startups across eight verticals: robotics, energy, health and biotech, artificial intelligence, advanced materials, cybersecurity, and space and communications. Rather than deploying capital as a passive LP, Moringa operates as a builder — providing strategic guidance, mentorship, and access to a global advisory network of 30+ domain experts, with structured programmes (Momentum, a 3-month commercialization track; Momentum for Healthcare, a clinical validation programme co-developed with Changi General Hospital) functioning as the firm's primary productized offering.

The firm's core technology stack is non-proprietary in the traditional product sense: Moringa does not develop software or hardware but instead assembles an institutional partnership ecosystem — Enterprise Singapore (StartupSG Accelerator network), IPOS International (IP strategy), JTC Corporation (innovation-district infrastructure), Tsinghua University (technology transfer), and Changi General Hospital (clinical validation) — that founders plug into alongside the equity cheque. The investment process is structured as Apply → Selection → Invest → Growth support, with a stated 100% review of all pitches.

The business model is that of an early-stage venture capital firm. Revenue is generated through investment returns (exit/IPO proceeds, follow-on upside) and, implicitly, management fees on committed capital from the Tembusu parent platform; specific AUM, fund size, and economics are not publicly disclosed. The firm is headquartered at #12-01 Royal Group Building, 3 Philip Street, Singapore, and operates with a lean internal team of five named professionals (Managing Partner Khoong Hock Yun, Partner Theodora Lai, Venture Partner Julian Low, Associate Director Investments Andrew Khan, Associate Joy Li) supported by a 30+ advisor network. As of the available data, only one portfolio investment is publicly confirmed: participation in H3 Zoom's US$3.6 million Series A in June 2026 (non-lead).

Name

Moringa Ventures

Legal name

Moringa Ventures

Website

https://moringa-ventures.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Moringa Ventures is a Singapore-based deep-tech venture builder, backed by Tembusu Partners, that writes first cheques (from S$250k) into early-stage startups across AI, robotics, energy, health/biotech, materials, cybersecurity, and space, and runs the Momentum and Momentum for Healthcare accelerator programmes.

Ownership category

akta.pro rank

Product category

Deep Tech Venture Capital

akta.pro primary industry

Venture Studios / Company Builders (FSANAAAH)

akta.pro secondary industry

Emerging Manager / Seeding Platforms (Multi-Manager) (FSANAGAF)

Keywords

• Venture capital
• Deep tech investing
• Startup accelerator
• Early stage funding
• Venture builder

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Returns: Moringa Ventures generates returns through equity investments in early-stage deep tech startups. The firm writes first cheques and provides follow-on support, expecting returns through exits or IPOs. They are backed by Tembusu Partners, a multi-stage private equity firm established in 2006 with a track record of scaling companies to successful exits.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Moringa Ventures is a Singapore-based deep tech venture builder that writes first cheques (from S$250k) into early-stage deep tech startups across AI, robotics, advanced materials, energy, health and biotech, cybersecurity, and space and communication. The firm combines venture building with institutional capital from Tembusu Partners, offering structured accelerator programmes (Momentum and Momentum for Healthcare) alongside strategic guidance, mentorship, and access to a global advisory network to take founders from first proof-of-concept to global scale.

Product overview

Moringa Ventures is a Singapore-based deep-tech venture builder backed by Tembusu Partners, dedicated to funding early-stage deep tech startups. Rather than operating a unified software platform, the firm offers two structured accelerator programmes: Momentum (a 3-month commercialization pathway programme) and Momentum for Healthcare (a clinical validation programme developed with Changi General Hospital). The firm provides investment capital starting from S$250,000, strategic guidance, mentorship, and access to a global advisory network to help founders build transformative technologies across AI/ML, robotics, cybersecurity, advanced materials, health and biotechnology, energy, and space technologies.

Differentiator

Problem solved

Functional benefit

Brands

• Momentum: A structured 3-month programme designed for early-stage deep tech ventures ready to develop pathways for commercialisation.
• Momentum for Healthcare

Products and services

• Momentum Programme
• Momentum for Healthcare / Clinical Innovation Programme
• First Cheque Deep Tech Investment

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and major.

• Changi General Hospital (CGH)coreStrategic or Co-development Partner · 20 April 2026CGH and Moringa Ventures signed an MOU to advance validation, testing, and adoption of biomedical technologies. The collaboration establishes a structured pathway for translating technologies from proof-of-concept (TRL 3-4) to commercial readiness (TRL 8-9), leveraging CGH's clinical expertise and infrastructure.
• Enterprise SingaporecoreStrategic or Co-development PartnerAs part of Singapore's national StartupSG Accelerator network, Moringa Ventures partners with Enterprise Singapore to scale deep tech startups with global ambition.
• IPOS InternationalmajorStrategic or Co-development PartnerThrough partnership with IPOS International, Moringa Ventures supports deep tech founders in navigating IP strategy and protection frameworks to scale with confidence.
• JTC CorporationmajorStrategic or Co-development PartnerThrough partnership with JTC Corporation, Moringa Ventures enables deep tech founders to build and scale within Singapore's innovation ecosystem.
• Tsinghua UniversitymajorStrategic or Co-development PartnerCollaboration with Tsinghua University's Office of Technology Transfer connects world-class research with venture-building expertise to bring scientific breakthroughs from lab to market.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SGInnovate: Singapore-focused deep tech investor backed by the Singapore government, investing across AI, biotech, medtech, and advanced engineering. Direct competitor for Singapore-based deep tech deals and a likely co-investor or counter-bidder on Moringa's target rounds.
• Wavemaker Partners: SEA-US early-stage venture fund with deep tech investing across AI, robotics, and enterprise software. Competes for the same Singapore-based founders and offers larger ticket sizes than Moringa's sub-S$1M cheques.
• Entrepreneur First: Talent-first venture builder that backs individuals before they form companies, with deep tech focus areas including AI and biotech. Comparable to Moringa in combining first-cheque investing with structured cohort-based programmes and founder formation.
• BEENEXT: Early-stage venture investor founded by ex-Tembusu leadership with strong SEA and India presence, investing from seed to Series A. Particularly comparable given the shared institutional heritage and similar first-cheque strategy into tech founders.
• SOSV: Global accelerator-VC running multiple vertical programmes (HAX for hardware, IndieBio for biotech, dlab for blockchain) — directly comparable to Moringa's model of sector-specific accelerator programmes coupled with early-stage investment capital.
• Antler: Global venture builder that invests early and provides hands-on support to founders across multiple geographies including Southeast Asia. Operates a similar thesis-driven, first-cheque venture-building model with structured programmes analogous to Moringa's Momentum.
• 500 Global: Global venture builder and accelerator (formerly 500 Startups) running seed programmes in dozens of countries including Singapore. Comparable in offering structured programmes, seed capital, and a global founder network.

Broad incumbents

• Techstars: Established global accelerator network with programmes across multiple verticals including healthtech and deep tech. Comparable in programme structure (3-month accelerators, mentor networks, demo days) but operates at much larger global scale.

Emerging players

• Helix Ventures: Early-stage deep tech and biotech investor with Singapore presence, focused on university-derived spinouts. Comparable to Moringa's thesis of backing research-backed teams transitioning from proof-of-concept to commercialisation.

Regional players

• Jungle Ventures: Singapore-headquartered VC investing across Southeast Asia with broader sector coverage including consumer and fintech, but with deep tech and enterprise exposure that overlaps Moringa's thesis. Different cheque size profile but same regional deal pool.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/moringa-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Moringa Ventures